Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Canerpaturev |
Trade Name | |
Synonyms | HSV-1 HF10|herpes simplex virus type 1 HF10|HF10 |
Drug Descriptions |
Canerpaturev (HF10) is a spontaneous herpes simplex virus (HSV) type I mutant variant, which is capable of infecting and lysing tumor cells, and may also lead to non-infected tumor cell death by increasing host immune response (PMID: 31193737). |
DrugClasses | |
CAS Registry Number | 1662666-66-1 |
NCIT ID | C88318 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Canerpaturev | Canerpaturev | 0 | 0 |
Canerpaturev + Ipilimumab | Canerpaturev Ipilimumab | 0 | 1 |
Canerpaturev + Nivolumab | Canerpaturev Nivolumab | 0 | 1 |